Family Medicine Medical Specialties News

South Korea seeks remdesivir to treat over 5,000 COVID patients: lawmaker

South Korea has asked Gilead Sciences Inc’s to supply enough of its anti-viral drug remdesivir to treat more than 5,000 COVID-19 patients in preparation for a potential second wave of infections, an opposition lawmaker said on Wednesday.

One of the few treatments shown to alter the course of COVID-10, remdesivir is in high demand, but there are concerns about its availability after Gilead allocated nearly all of its supply to the United States over the next three months.

South Korea said last week it has 33 severely ill patients who are eligible for the intravenously-administered medicine which helped to shorten hospital recovery times in a clinical trial.

Read More

Meeta Ramnani
Meeta Ramnani
Meeta develops credible content about various markets based on deep research, opinions from experts and inputs from industry leaders. As the managing editor at Smart Industry News, she assures that every piece of news and article adds to the knowledge of decision makers. An avid bike rider, Meeta, is a postgraduate from Indian Institute of Journalism and New Media (IIJNM) Bangalore, where her specialization was Business Journalism. She carries experience from mainstream print media including The Times Group and Sakal Media Group.